BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37719656)

  • 1. Virus-Like Particles Assembled Using Respiratory Syncytial Virus Matrix Protein Elicit Protective Immunity in Mice.
    Lee SH; Chu KB; Kim MJ; Quan FS
    Infect Drug Resist; 2023; 16():6099-6110. PubMed ID: 37719656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-like Particle Vaccine Expressing the Respiratory Syncytial Virus Pre-Fusion and G Proteins Confers Protection against RSV Challenge Infection.
    Lee SH; Chu KB; Kim MJ; Mao J; Eom GD; Yoon KW; Ahmed MA; Quan FS
    Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein.
    Cullen LM; Blanco JC; Morrison TG
    J Transl Med; 2015 Nov; 13():350. PubMed ID: 26541285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the protection elicited by virus-like particles expressing the RSV pre-fusion F and tandem repeated G proteins against RSV rA2 line19F infection in mice.
    Kim MJ; Chu KB; Lee SH; Mao J; Eom GD; Yoon KW; Moon EK; Quan FS
    Respir Res; 2024 Jan; 25(1):7. PubMed ID: 38178222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
    Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
    J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term and memory immune responses in mice against Newcastle disease virus-like particles containing respiratory syncytial virus glycoprotein ectodomains.
    Schmidt MR; McGinnes LW; Kenward SA; Willems KN; Woodland RT; Morrison TG
    J Virol; 2012 Nov; 86(21):11654-62. PubMed ID: 22896618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles.
    McGinnes Cullen L; Schmidt MR; Morrison TG
    J Virol; 2019 May; 93(9):. PubMed ID: 30760576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins.
    Lee S; Quan FS; Kwon Y; Sakamoto K; Kang SM; Compans RW; Moore ML
    Antiviral Res; 2014 Nov; 111():129-35. PubMed ID: 25239522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single intranasal administration of virus-like particle vaccine induces an efficient protection for mice against human respiratory syncytial virus.
    Jiao YY; Fu YH; Yan YF; Hua Y; Ma Y; Zhang XJ; Song JD; Peng XL; Huang J; Hong T; He JS
    Antiviral Res; 2017 Aug; 144():57-69. PubMed ID: 28529001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-like particles containing a prefusion-stabilized F protein induce a balanced immune response and confer protection against respiratory syncytial virus infection in mice.
    Luo J; Qin H; Lei L; Lou W; Li R; Pan Z
    Front Immunol; 2022; 13():1054005. PubMed ID: 36578490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of the respiratory syncytial virus f protein in virus-like particles impacts generation of B cell memory.
    Schmidt MR; McGinnes-Cullen LW; Kenward SA; Willems KN; Woodland RT; Morrison TG
    J Virol; 2014 Sep; 88(17):10165-76. PubMed ID: 24965456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins.
    McGinnes LW; Gravel KA; Finberg RW; Kurt-Jones EA; Massare MJ; Smith G; Schmidt MR; Morrison TG
    J Virol; 2011 Jan; 85(1):366-77. PubMed ID: 20980510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice.
    Quan FS; Kim Y; Lee S; Yi H; Kang SM; Bozja J; Moore ML; Compans RW
    J Infect Dis; 2011 Oct; 204(7):987-95. PubMed ID: 21881112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine immune responses to virus-like particle-associated pre- and postfusion forms of the respiratory syncytial virus F protein.
    McGinnes Cullen L; Schmidt MR; Kenward SA; Woodland RT; Morrison TG
    J Virol; 2015 Jul; 89(13):6835-47. PubMed ID: 25903340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model.
    Cox RG; Erickson JJ; Hastings AK; Becker JC; Johnson M; Craven RE; Tollefson SJ; Boyd KL; Williams JV
    J Virol; 2014 Jun; 88(11):6368-79. PubMed ID: 24672031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis.
    Hwang HS; Kwon YM; Lee JS; Yoo SE; Lee YN; Ko EJ; Kim MC; Cho MK; Lee YT; Jung YJ; Lee JY; Li JD; Kang SM
    Antiviral Res; 2014 Oct; 110():115-23. PubMed ID: 25110201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-like particle vaccine by intranasal vaccination elicits protective immunity against respiratory syncytial viral infection in mice.
    Cai M; Wang C; Li Y; Gu H; Sun S; Duan Y; Lai C; Wang K; Yang X; Xing L; Zhang P; Wang Z; Zhang S; Guo X; Liu S; Tong Y; Wang X; Yang P
    Acta Biochim Biophys Sin (Shanghai); 2017 Jan; 49(1):74-82. PubMed ID: 27974288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein.
    Cimica V; Boigard H; Bhatia B; Fallon JT; Alimova A; Gottlieb P; Galarza JM
    Clin Vaccine Immunol; 2016 Jun; 23(6):451-9. PubMed ID: 27030590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.
    Murawski MR; McGinnes LW; Finberg RW; Kurt-Jones EA; Massare MJ; Smith G; Heaton PM; Fraire AE; Morrison TG
    J Virol; 2010 Jan; 84(2):1110-23. PubMed ID: 19889768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two RSV Platforms for G, F, or G+F Proteins VLPs.
    Ha B; Yang JE; Chen X; Jadhao SJ; Wright ER; Anderson LJ
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32824936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.